RXO, Inc.

As of June 30, 2026, RXO, Inc. carries a market capitalization of 3.96B, placing it among publicly traded companies globally. Its enterprise value stands at 4.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

RXO, Inc.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, RXO, Inc. has 164.92M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.76, and the price-to-book ratio stands at 3.00.

As of June 30, 2026, RXO, Inc. trades at an EV/EBITDA multiple of 174.50 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.86 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.58B versus a market cap of 3.96B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, RXO, Inc. maintains a current ratio of 1.27, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.34, indicating elevated leverage, while an interest coverage ratio of 0.83 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, RXO, Inc. posted a negative return on equity (ROE) of -6.79, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.15, reflecting losses generated across the asset base. The company generates approximately 568,092.49 in revenue per employee across its workforce of 9,381.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, RXO, Inc. recorded an income tax benefit of -15.76M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -107.66M and -91.91M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, RXO, Inc.'s stock has gained approximately 68.42% over the past 52 weeks. The 50-day moving average sits at 20.19, while the 200-day moving average is 18.03.

Over the twelve months ended June 30, 2026, RXO, Inc. generated 5.33B in revenue and converted that into -91.91M in net income, yielding earnings per share of -0.54. EBITDA reached 26.26M, while operating income came in at -12.25M.

As of June 30, 2026, RXO, Inc. holds 13.13M in cash and equivalents against 637.22M in total debt, resulting in a net debt position of 420.14M. Total book value stands at 1.32B, with working capital of 287.97M providing operational flexibility.

RXO, Inc. produced -14.88M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -51.64M in capital expenditures, free cash flow totaled -66.52M - equivalent to -0.39 per share.

Over the twelve months ended June 30, 2026, RXO, Inc. posted a gross margin of 13.17, reflecting its pricing power and cost economics. The operating margin of -0.23 and net profit margin of -1.72 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -1.64: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.57, meaning RXO, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, RXO, Inc. has an Altman Z-Score of 4.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.